Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07533890
NA
Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease
Sponsor: Insel Gruppe AG, University Hospital Bern
View on ClinicalTrials.gov
Summary
In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.
Official title: Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease - an Explanatory 1:1 Randomized Controlled Cross-Over Proof-of-Concept Trial With Blinded Outcome Assessment
Key Details
Gender
All
Age Range
5 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-04
Completion Date
2028-12
Last Updated
2026-04-16
Healthy Volunteers
No
Conditions
Interventions
OTHER
Probiotic Formula
multi-strain probiotics
OTHER
Observation
Observation